SGMO - Wutah pendapatan taun lumaku Sangamo Therapeutics

Sangamo Therapeutics (SGMO) ensures the preservation of biomaterials through strict cryogenic control during transport. The company relies on a unique staff of genome modification experts with minimal employee turnover. Leadership in "zinc finger" technology expands its market reach within kidney and CNS therapies. The last twelve months (LTM) revenue growth rate demonstrates development dynamics, where -31.20 serves as the current metric level.
Sangamo BioSciences (SGMO) - rincian metrik lan laporan keuangan

This indicator measures business expansion rates, smoothing short-term revenue fluctuations over twelve months to identify the company's true scaling dynamics. By analyzing the TTM year-over-year revenue chart, an investor can assess the capitalization potential of Sangamo Therapeutics (SGMO), which is supported by its technological dominance in gene editing and its exclusive pricing power over future therapeutic solutions.